Evommune EVMN
NYSE EVMN
$5.18 -0.20 (-3.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

Evommune (EVMN) Enterprise Value (2025 - 2026)

Updated

Evommune (EVMN) recorded Enterprise Value of $281.39 million in Q2 2026, down 54.4% from the prior quarter.

Analysis

Evommune (EVMN) Enterprise Value (2025 - 2026) Analysis & Trends

On a TTM basis, Evommune's Enterprise Value came in at -$155.33 million as of Jun 30, 2026; for FY2025, it came in at -$44.14 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Evommune 186.46 Mn -451.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 281.39 Mn
Mar 31, 2026 616.60 Mn
Dec 31, 2025 -44.14 Mn
API Access

Evommune Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=EVMN&period=max&api_key=YOUR_API_KEY